Eurofins MWG Operon has worked alongside Genomatix Software GmbH to develop a complete human exome array, based on Roche NimbleGen sequence capture technology.
“We are pleased to offer this comprehensive service for human exome capture, targeted resequencing
and data interpretation. The development of the new exome array was necessary, as currently available versions of human whole-exome capture products do not include or do not efficiently capture many medically relevant genes, so that researchers might miss important information.” says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services.
Klaus May, Chief Business Officer of Genomatix, says: “Based on the latest human reference genome sequence hg19/NCBI37/GRCh37 and our proprietary ElDorado extended genome annotation 02-2010 we developed a human exome with 282,363 target regions, representing 240,402 exonic regions. We included splice sites and added 83,246 proximal promoter regions plus 678 microRNAs in order to allow the researcher to obtain the most comprehensive picture that exon capturing technology allows today. The combined expertise of Eurofins and Genomatix enables us to offer the most advanced whole exome analysis service available to date.”back to top » |
clinical diagnostics
